Patents Assigned to Mogrify Limited
  • Patent number: 12614607
    Abstract: A method for maintaining a cell in vitro that comprises the steps of: providing a cell of interest in cell culture, determining differential breadth of histone 3 trimethylated at lysine 4 (H3K4me3) modified regions and a differential broadness score for each protein-coding gene in said cell, determining a network score for each protein-coding gene in said cell based on the differential broadness score and interactions between the protein products of each protein-coding gene over at least one network, and determining a cell identity score for each protein-coding gene in said cell based on a combination of the differential broadness score and network scores. The cell identity scores are used to prioritise protein-coding genes thereby identifying cell identity genes for said cell, which encode factors associated with cell identity. The cell of interest is cultured in the presence of said factors, thereby maintaining the cell identity of the cell of interest.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: April 28, 2026
    Assignees: Monash University, Mogrify Limited, National University of Singapore
    Inventors: Owen Rackham, Enrico Petretto, Uma Kamaraj, Jose Polo, Joseph Chen
  • Publication number: 20200216813
    Abstract: The present invention relates to methods and compositions, including kits for reprogramming a source cell to a cardiomyocyte, the method comprising increasing the protein expression of one or more transcription factors, or variants thereof, in the source cell, wherein the source cell is reprogrammed to exhibit at least one characteristic of a cardiomyocyte.
    Type: Application
    Filed: June 21, 2018
    Publication date: July 9, 2020
    Applicant: Mogrify Limited
    Inventors: Julian Gough, Owen Rackham, Justin Cooper-White
  • Publication number: 20200165568
    Abstract: The present invention relates to methods and compositions for reprogramming a source cell to produce a chondrocyte, the method comprising activating or increasing the protein expression of one or more transcription factors, or variants thereof, in the source cell.
    Type: Application
    Filed: June 21, 2018
    Publication date: May 28, 2020
    Applicant: Mogrify Limited
    Inventors: Wael Kafienah, Julian Gough